Orion Biotech Opportunities Statistics Share Statistics Orion Biotech Opportunities has n/a
shares outstanding. The number of shares has increased by 25%
in one year.
Shares Outstanding n/a Shares Change (YoY) 25% Shares Change (QoQ) 0% Owned by Institutions (%) n/a Shares Floating 18.5M Failed to Deliver (FTD) Shares 108,200 FTD / Avg. Volume 133.08%
Short Selling Information The latest short interest is 2.87K, so 0% of the outstanding
shares have been sold short.
Short Interest 2.87K Short % of Shares Out n/a Short % of Float n/a Short Ratio (days to cover) 1
Valuation Ratios The PE ratio is 10.92 and the forward
PE ratio is null.
Orion Biotech Opportunities's PEG ratio is
0.
PE Ratio 10.92 Forward PE n/a PS Ratio 0 Forward PS n/a PB Ratio 1.03 P/FCF Ratio -533.5 PEG Ratio 0
Financial Ratio History Enterprise Valuation Orion Biotech Opportunities has an Enterprise Value (EV) of 200.73M.
EV / Sales 0 EV / EBITDA -19.02 EV / EBIT -532.8 EV / FCF -532.8
Financial Position The company has a current ratio of 6.5,
with a Debt / Equity ratio of 0.
Current Ratio 6.5 Quick Ratio 6.5 Debt / Equity 0 Debt / EBITDA n/a Debt / FCF n/a Interest Coverage 0
Financial Efficiency Return on Equity is 9.44% and Return on Invested Capital is -0.93%.
Return on Equity 9.44% Return on Assets 9.06% Return on Invested Capital -0.93% Revenue Per Employee n/a Profits Per Employee n/a Employee Count undefined Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax -9.66M Effective Tax Rate -110.28%
Stock Price Statistics The stock price has increased by 0% in the
last 52 weeks. The beta is 0, so Orion Biotech Opportunities's
price volatility has been lower than the market average.
Beta 0 52-Week Price Change n/a 50-Day Moving Average 10.27 200-Day Moving Average 10.04 Relative Strength Index (RSI) 48.06 Average Volume (20 Days) 81,306
Income Statement
Revenue n/a Gross Profit n/a Operating Income -900K Net Income 18.41M EBITDA -10.56M EBIT -10.56M Earnings Per Share (EPS) 0.92
Full Income Statement Balance Sheet The company has 265.72K in cash and 0 in
debt, giving a net cash position of 265.72K.
Cash & Cash Equivalents 265.72K Total Debt n/a Net Cash n/a Retained Earnings -7.79M Total Assets 203.33M Working Capital 371.73K
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -376.76K
and capital expenditures 0, giving a free cash flow of -376.76K.
Operating Cash Flow -376.76K Capital Expenditures n/a Free Cash Flow -376.76K FCF Per Share -0.02
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
